Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03073070 · ClinicalTrials.gov registry record · Phase 1
RBC Lifespan Measurement in Diabetic Children
A Phase 1 study of Diabetes and Red Blood Cell Survival, sponsored by Guohua An.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT03073070 is a Phase 1 study of Diabetes and Red Blood Cell Survival that has completed, run by Guohua An. The registered enrollment target is 6 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03073070, a Phase 1 study of Diabetes and Red Blood Cell Survival, has completed, sponsored by Guohua An.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
HbA1c, a measure of mean blood glucose over the lifespan of a red blood cell (RBC), is a marker of increasing importance both for assessing glycemic control in children with known diabetes and for the diagnosis of diabetes in children. HbA1c has demonstrated poor reliability in diagnosis and management of pediatric diabetes and the most plausible reason for this unreliability is that the reference ranges of HbA1c were established based on 120-day RBC lifespan observed in adults, without considering the RBC lifespan difference between children and adults. The proposed studies will for the first time determine RBC lifespan in diabetic children
Conditions Studied
Interventions
- DRUG biotin labeled RBCs
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2019-09-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03073070
The ClinicalTrials.gov registry entry for NCT03073070 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The listed sponsor is Guohua An, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which biotin labeled RBCs is the first listed.
NCT03073070 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT03073070 about?
NCT03073070 is a clinical study titled "RBC Lifespan Measurement in Diabetic Children". HbA1c, a measure of mean blood glucose over the lifespan of a red blood cell (RBC), is a marker of increasing importance both for assessing glycemic control in children with known diabetes and for the diagnosis of diabetes in children. HbA1c has demonstrated poor reliability in diagnosis and managem...
What is the current status of trial NCT03073070?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2017-11-15. Estimated completion is 2019-09-15.
What conditions does trial NCT03073070 study?
This clinical trial studies the following conditions: Diabetes, Red Blood Cell Survival.
What interventions are being tested in trial NCT03073070?
The interventions under investigation include: biotin labeled RBCs (DRUG).
Who is sponsoring clinical trial NCT03073070?
This trial is sponsored by Guohua An, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03073070 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mitigating the Pro-inflammatory Phenotype of Obesity
RECRUITING · Phase 1
-
Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
RECRUITING · Phase 1
-
Insulin Balanced Infusion System
ACTIVE NOT RECRUITING · Phase 1
-
Ability of a Tea Leaf Extracts Preparation to Slow Down Carbohydrate and Fat Absorption
COMPLETED · Phase 1
-
Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
COMPLETED · Phase 1
-
Family Management of Childhood Diabetes Study
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.